Diagnostic News and Research

RSS

USPTO grants patent to Rosetta's human hsa-miR-497 for use in diagnostic tests

Rosetta Genomics today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,943,745, which is related to human hsa-miR-497 and its variants and covers the composition of matter.

10 May 2011

New research shows iPhone app can accurately detect stroke

New research from the University of Calgary's Faculty of Medicine shows that doctors can make a stroke diagnosis using an iPhone application with the same accuracy as a diagnosis at a medical computer workstation.

10 May 2011

Three Ontario projects set to further knowledge and discovery in biomonitoring, drug development

As part of the Genome Canada Large-Scale Applied Research Project Competition, which as a whole awarded over $58 million to 16 projects across the country, the researchers in Ontario will be focusing on biomonitoring, understanding gene function with the aim of identifying genes or proteins for drug targets, and the creation of synthetic antibodies to target cancers and other diseases.

9 May 2011

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract. The Expect Needle received FDA clearance and CE Mark approval earlier this year and is being marketed in the U.S., Europe and other international markets.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Socioeconomic status may contribute to celiac diagnostic disparity

Income is a pivotal factor in whether a patient without common symptoms of celiac disease is accurately diagnosed with the digestive condition, according to a new study from the Beth Israel Deaconess Medical Center in Boston, MA.

9 May 2011

Study reveals autism prevalence may be higher than current estimates in Korean children

Autism may be more common worldwide than previously thought, according to researchers from the George Washington University and Yale University.

9 May 2011

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Cardiologists from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research at The Heart Rhythm Society's 32nd Annual Scientific Sessions, May 4 -7 in San Francisco, California.

9 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.

6 May 2011

BSX announces international launch and first implant of new cardiac devices

Boston Scientific Corporation today announced the launch and first implants of its ENERGEN and PUNCTUA cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators in Europe and other international markets.

6 May 2011

CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meeting

Cambridge Heart, Inc. a developer of non-invasive diagnostic tests for cardiac disease, today announced that new data presented at the Heart Rhythm Society's 32nd Annual Scientific Sessions in San Francisco confirm the diagnostic value of Microvolt T-wave Alternans testing in identifying patients at risk of sudden cardiac arrest.

6 May 2011

Scientists use new technologies to identify genetic cause of Kufs disease

Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.

6 May 2011

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.

6 May 2011

BD MAX Open System for molecular testing launched in Europe

BD Diagnostics, a segment of BD, today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced testing services that elevate the standards of care at their institutions.

From BD (Becton, Dickinson and Company) 6 May 2011

Diagnostic News and Research

USPTO grants patent to Rosetta's human hsa-miR-497 for use in diagnostic tests

New research shows iPhone app can accurately detect stroke

Three Ontario projects set to further knowledge and discovery in biomonitoring, drug development

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Socioeconomic status may contribute to celiac diagnostic disparity

Study reveals autism prevalence may be higher than current estimates in Korean children

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

BSX announces international launch and first implant of new cardiac devices

CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meeting

Scientists use new technologies to identify genetic cause of Kufs disease

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

BD MAX Open System for molecular testing launched in Europe

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

Mammogram appointments delayed by up to 148 days: NYC report

How to choose a microarray service provider

Researchers present evidence from first ever general population survey of autism in adulthood

New non-invasive blood test may detect early stage Alzheimer's

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News